Renaissance Capital logo

Achillion Pharmaceuticals , Nasdaq: ACHN

Develops novel treatments for infectious diseases, including HIV and Hepatitis C.

Industry: Health Care

First Day Return: +7.7%

Industry: Health Care

Develops novel treatments for infectious diseases, including HIV and Hepatitis C.
more less
IPO Data
IPO File Date 03/31/2006
Offer Price $11.50
Price Range $14.00 - $16.00
Offer Shares (mm) 4.5
Deal Size ($mm) $52
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 10/25/2006
Offer Price IPO Intelligence Only
Price Range IPO Intelligence Only
Offer Shares (mm) IPO Intelligence Only
Deal Size ($mm) $52
Lock-Up Date IPO Intelligence Only
Street Research IPO Intelligence Only
Underwriters
IPO Intelligence Only
Company Data
Headquarters New Haven, CT, United States
Founded 1998
Employees at IPO 65
Website www.achillion.com

Achillion Pharmaceuticals (ACHN) Performance